Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 4
1976 4
1978 1
1979 1
1980 1
1981 5
1982 3
1983 4
1984 4
1985 2
1986 1
1987 1
1988 1
1989 3
1990 4
1991 1
1992 3
1993 6
1994 5
1995 2
1996 1
1997 1
1998 3
1999 4
2000 3
2001 3
2002 4
2003 4
2004 4
2005 6
2006 5
2007 5
2008 5
2009 2
2010 7
2011 9
2012 4
2013 3
2014 3
2016 1
2017 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Results by year
Filters applied: . Clear all
Page 1
Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up.
Pothuri B, Brodsky AL, Sparano JA, Blank SV, Kim M, Hershman DL, Tiersten A, Kiesel BF, Beumer JH, Liebes L, Muggia F. Pothuri B, et al. Among authors: liebes l. Cancer Chemother Pharmacol. 2020 Apr;85(4):741-751. doi: 10.1007/s00280-020-04030-2. Epub 2020 Feb 13. Cancer Chemother Pharmacol. 2020. PMID: 32055930 Free PMC article. Clinical Trial.
Glutathione dehydrogenase (ascorbate).
Stahl RL, Liebes LF, Silber R. Stahl RL, et al. Among authors: liebes lf. Methods Enzymol. 1986;122:10-2. doi: 10.1016/0076-6879(86)22140-0. Methods Enzymol. 1986. PMID: 3702678 No abstract available.
Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer.
Alberts DS, Markman M, Muggia F, Ozols RF, Eldermire E, Bookman MA, Chen T, Curtin J, Hess LM, Liebes L, Young RC, Trimble E. Alberts DS, et al. Among authors: liebes l. Gynecol Oncol. 2006 Dec;103(3):783-92. doi: 10.1016/j.ygyno.2006.09.012. Epub 2006 Oct 27. Gynecol Oncol. 2006. PMID: 17070570 Free PMC article.
127 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page